Close
Nordic 9Nordic 9

CE-Ventures (investor - Corporate Investor)

United Arab Emirates
See something wrong or missing? Let us know

CE-Ventures, the corporate venture capital platform of Crescent Enterprises from the United Arab Emirates

Average round investment:16.67M USD
Average number per year:1.5
Distribution: 2025 (1)2023 (2)
Portfolio companies: France Exeliom BiosciencesDenmark Freya Biosciences
Mostly invests in: France France (2) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to CE-Ventures

Name Criteria
France Prunay Impact Studio
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Radouane Kharbichi
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mid Atlantic Bio Angels
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Aurinvest
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Broadview Ventures
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Anaxago
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
United States Ataraxia
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Sweden Niklas Zennström
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
France Galia Gestion
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Auriga
72%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top